AXDX stock forecast
Our latest prediction for Accelerate Diagnostics, Inc.'s stock price was made on the May 15, 2018 when the stock price was at 20.10$.
In the short term (2weeks), AXDX's stock price should outperform the market by 3.70%. During that period the price should oscillate between -7.53% and +11.43%.
In the medium term (3months), AXDX's stock price should outperform the market by 4.67%. During that period the price should oscillate between -16.83% and +27.21%.Get email alerts
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.
At the moment the company generates 6M USD in revenues.
On its last earning announcement, the company reported a loss of -1.50$ per share.
The book value per share is 1.75$
Three months stock forecastMay 15, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|